A phase II trial of oral idarubicin plus dibromodulcitol in advanced breast cancer

Eur J Cancer Clin Oncol. 1989 Jan;25(1):141-3. doi: 10.1016/0277-5379(89)90063-1.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Middle Aged
  • Mitolactol / administration & dosage
  • Neutropenia / chemically induced
  • Thrombocytopenia / chemically induced

Substances

  • Mitolactol
  • Idarubicin